Quanterix (QTRX) Financials: History & Chart

Quanterix Corporation(QTRX)

Medical - Devices · Billerica, MA

$3.50-0.31 (-8.14%)

Delayed quote: Oct 6, 2026, 2:30 PM EDT

About Quanterix Corporation

Quanterix Corporation, based in Billerica, Massachusetts, is a life sciences enterprise dedicated to pioneering and commercializing advanced digital immunoassay platforms. These sophisticated systems are designed to enhance precision health in both scientific research and diagnostic applications, reaching markets across North America, Europe, the Middle East, Africa, and the Asia Pacific regions. The company's core offerings include several innovative instruments: The HD-X instrument, which provides highly sensitive and automated multiplex protein detection. The SR-X instrument, enabling researchers to leverage Simoa detection technology for diverse uses, such as the direct detection of nucleic acids. The SP-X instrument, which utilizes Simoa planar array technology for conducting multiplex chemiluminescent immunoassays. Alongside these platforms, Quanterix also supplies crucial consumables, including assay kits and reagents. In addition to its product line, the company delivers various contract research services, encompassing sample analysis, the development of custom "homebrew" assays, and other specialized research and development projects. Quanterix's operational focus spans critical health areas like neurology, oncology, cardiology, infectious diseases, and inflammation. Its clientele within the life science research sector primarily consists of laboratories affiliated with academic and governmental research institutions, as well as pharmaceutical, biotechnology, and contract research organizations. Sales are managed through a multifaceted approach, combining a direct sales force, dedicated support organizations, and a network of distributors or sales agents. The company was initially incorporated in 2007 as Digital Genomics, Inc., before rebranding to Quanterix Corporation in August of the same year.

Billerica, MA

450 employees

www.quanterix.com

Healthcare / Medical - Devices

Sector: Healthcare
Industry: Medical - Devices
CEO: Everett V. Cunningham

View full financials

Financials

SEC Filings

Quarterly Income Statement (USD)

Swipe horizontally to review earlier periods. The line-item column stays pinned.

Quarterly Report	TTM	Quarter ended Jun 2026	Quarter ended Mar 2026	Quarter ended Dec 2025	Quarter ended Sep 2025	Quarter ended Jun 2025	Quarter ended Mar 2025	Quarter ended Dec 2024	Quarter ended Sep 2024
Revenue	153.33M	32.91M	36.41M	43.85M	40.15M	24.45M	30.27M	34.11M	35.41M
Cost of Goods Sold	87.92M	20.23M	20.85M	23.82M	23.03M	13.18M	13.92M	12.99M	15.66M
Gross Profit	65.32M	12.67M	15.57M	19.96M	17.12M	11.28M	16.36M	21.11M	19.75M
Gross Profit Margin	42.6%	38.5%	42.7%	45.5%	42.6%	46.1%	54.0%	61.9%	55.8%
Total Operating Expenses	197.47M	62.10M	37.09M	43.83M	54.45M	48.38M	42.72M	35.88M	31.50M
Research & Development	31.95M	7.82M	7.32M	8.80M	8.01M	9.08M	10.04M	8.07M	8.10M
Selling, General & Administrative	131.60M	27.35M	29.77M	35.14M	39.35M	31.65M	32.74M	28.87M	23.80M
Operating Income (EBIT)	-132.15M	-49.43M	-21.53M	-23.87M	-37.33M	-37.10M	-26.37M	-14.77M	-11.75M
Operating Margin	-86.2%	-150.2%	-59.1%	-54.4%	-93.0%	-151.7%	-87.1%	-43.3%	-33.2%
Income Before Tax (EBT)	-125.31M	-48.99M	-17.55M	-22.77M	-36.00M	-30.09M	-23.42M	-11.64M	-8.21M
Interest Income	4.26M	761K	892K	1.16M	1.45M	2.69M	3.27M	3.49M	3.54M
Interest Expense	N/A	N/A	N/A	N/A	N/A	N/A	N/A	N/A	N/A
Other Income/Expense	6.85M	443K	3.98M	1.10M	1.33M	7.01M	2.95M	3.13M	3.54M
Net Income	-123.11M	-48.93M	-17.54M	-23.12M	-33.52M	-30.01M	-20.50M	-11.63M	-8.35M
Income Tax Expense	-2.20M	-54K	-7K	345K	-2.48M	-73K	-2.91M	-8K	145K
Net Profit Margin	-80.3%	-148.7%	-48.2%	-52.7%	-83.5%	-122.7%	-67.7%	-34.1%	-23.6%
EBITDA	-106.98M	-42.49M	-15.13M	-16.62M	-32.74M	-34.25M	-24.18M	-11.15M	-10.97M
EBITDA Margin	-69.8%	-129.1%	-41.5%	-37.9%	-81.6%	-140.1%	-79.9%	-32.7%	-31.0%
Depreciation & Amortization	25.17M	6.94M	6.40M	7.25M	4.58M	2.85M	2.19M	3.62M	776K
EPS Basic	-2.63	-1.04	-0.37	-0.49	-0.73	-0.77	-0.53	-0.30	-0.22
EPS Diluted	-2.63	-1.04	-0.37	-0.49	-0.73	-0.77	-0.53	-0.30	-0.22
Weighted Average Basic Shares	46.98M	46.98M	46.98M	46.78M	46.06M	38.89M	38.72M	38.55M	38.45M
Weighted Average Diluted Shares	46.98M	46.98M	46.98M	46.78M	46.06M	38.89M	38.72M	38.55M	38.45M

Annual Income Statement (USD)

Swipe horizontally to review earlier years. The line-item column stays pinned.

Annual Report	12/31/2025	12/31/2024	12/31/2023	12/31/2022	12/31/2021	12/31/2020	12/31/2019	12/31/2018
Revenue	138.65M	135.44M	121.14M	105.52M	110.56M	86.38M	56.73M	37.63M
Cost of Goods Sold	73.94M	54.32M	48.14M	60.16M	45.78M	38.20M	29.90M	19.65M
Gross Profit	64.72M	81.12M	73.00M	45.36M	64.77M	48.18M	26.84M	17.98M
Gross Profit Margin	46.7%	59.9%	60.3%	43.0%	58.6%	55.8%	47.3%	47.8%
Total Operating Expenses	174.53M	133.74M	118.99M	149.63M	121.29M	79.77M	68.44M	49.07M
Research & Development	35.92M	31.08M	26.06M	26.81M	28.38M	20.17M	16.19M	15.29M
Selling, General & Administrative	138.85M	104.64M	92.82M	91.85M	92.91M	59.59M	52.25M	33.78M
Operating Income (EBIT)	-109.81M	-52.62M	-45.99M	-104.26M	-56.52M	-31.58M	-41.60M	-31.55M
Operating Margin	-79.2%	-38.8%	-38.0%	-98.8%	-51.1%	-36.6%	-73.3%	-83.8%
Income Before Tax (EBT)	-112.27M	-38.10M	-27.64M	-99.41M	-55.58M	-31.91M	-40.98M	-31.05M
Interest Income	8.57M	14.65M	15.84M	5.13M	N/A	N/A	627K	46K
Interest Expense	N/A	N/A	N/A	N/A	403K	273K	N/A	N/A
Other Income/Expense	-2.46M	14.52M	18.36M	4.85M	937K	-322K	617K	39K
Net Income	-107.15M	-38.53M	-28.35M	-99.57M	-55.55M	-31.53M	-40.80M	-31.05M
Income Tax Expense	-5.12M	434K	719K	164K	-36K	-376K	-187K	25K
Net Profit Margin	-77.3%	-28.4%	-23.4%	-94.4%	-50.2%	-36.5%	-71.9%	-82.5%
EBITDA	-90.89M	-44.26M	-37.70M	-98.86M	-51.64M	-27.27M	-38.59M	-30.20M
EBITDA Margin	-65.6%	-32.7%	-31.1%	-93.7%	-46.7%	-31.6%	-68.0%	-80.2%
Depreciation & Amortization	18.93M	8.36M	8.29M	5.41M	4.88M	4.31M	3.01M	1.35M
EPS Basic	-2.51	-1.00	-0.86	-2.61	-1.60	-1.07	-1.63	-1.41
EPS Diluted	-2.51	-1.00	-0.86	-2.61	-1.60	-1.07	-1.63	-1.39
Weighted Average Basic Shares	42.64M	38.37M	37.59M	36.99M	36.00M	29.59M	25.09M	21.99M
Weighted Average Diluted Shares	42.64M	38.37M	37.59M	36.99M	36.00M	29.59M	25.09M	22.37M

Values are displayed in USD. Negative numbers shown in red.

Values are displayed in USD. Negative numbers are shown in red.